Elham Kayvanpour1,2, Farbod Sedaghat-Hamedani1,2, Ali Amr1,2, Alan Lai1, Jan Haas1,2, Daniel B Holzer1, Karen S Frese1,2, Andreas Keller3, Katrin Jensen4, Hugo A Katus1,2, Benjamin Meder5,6. 1. Department of Medicine III, University of Heidelberg, INF 410, 69120, Heidelberg, Germany. 2. DZHK (German Centre for Cardiovascular Research), Berlin, Germany. 3. Clinical Bioinformatics, Saarland University, Saarbrücken, Germany. 4. Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany. 5. Department of Medicine III, University of Heidelberg, INF 410, 69120, Heidelberg, Germany. Benjamin.Meder@med.uni-heidelberg.de. 6. DZHK (German Centre for Cardiovascular Research), Berlin, Germany. Benjamin.Meder@med.uni-heidelberg.de.
Abstract
AIMS: Routine genetic testing in Dilated Cardiomyopathy (DCM) has recently become reality using Next-Generation Sequencing. Several studies have explored the relationship between genotypes and clinical phenotypes to support risk estimation and therapeutic decisions, however, most studies are small or restricted to a few genes. This study provides to our knowledge the first systematic meta-analysis on genotype-phenotype associations in DCM. METHODS AND RESULTS: We retrieved PubMed/Medline literature on genotype-phenotype associations in patients with DCM and mutations in LMNA, PLN, RBM20, MYBPC3, MYH7, TNNT2 and TNNI3. We summarized and extensively reviewed all studies that passed selection criteria and performed a meta-analysis on key phenotypic parameters. Together, 48 studies with 8097 patients were included. Furthermore, we reviewed recent studies investigating genotype-phenotype associations in DCM patients with TTN mutations. The average frequency of mutations in the investigated genes was between 1 and 5 %. The mean age of DCM onset was the beginning of the fifth decade for all genes. Heart transplantation (HTx) rate was highest in LMNA mutation carriers (27 %), while RBM20 mutation carriers were transplanted at a markedly younger age (mean 28.5 years). While 73 % of DCM patients with LMNA mutations showed cardiac conduction diseases, low voltage was the reported ECG hallmark in PLN mutation carriers. The frequency of ventricular arrhythmia in DCM patients with LMNA (50 %) and PLN (43 %) mutations was significantly higher. The penetrance of DCM phenotype in subjects with TTN truncating variants increased with age and reached 100 % by age of 70. CONCLUSION: A pooled analysis of available genotype-phenotype data shows a higher prevalence of sudden cardiac death (SCD), cardiac transplantation, or ventricular arrhythmias in LMNA and PLN mutation carriers compared to sarcomeric gene mutations. This study will further support the clinical interpretation of genetic findings.
AIMS: Routine genetic testing in Dilated Cardiomyopathy (DCM) has recently become reality using Next-Generation Sequencing. Several studies have explored the relationship between genotypes and clinical phenotypes to support risk estimation and therapeutic decisions, however, most studies are small or restricted to a few genes. This study provides to our knowledge the first systematic meta-analysis on genotype-phenotype associations in DCM. METHODS AND RESULTS: We retrieved PubMed/Medline literature on genotype-phenotype associations in patients with DCM and mutations in LMNA, PLN, RBM20, MYBPC3, MYH7, TNNT2 and TNNI3. We summarized and extensively reviewed all studies that passed selection criteria and performed a meta-analysis on key phenotypic parameters. Together, 48 studies with 8097 patients were included. Furthermore, we reviewed recent studies investigating genotype-phenotype associations in DCMpatients with TTN mutations. The average frequency of mutations in the investigated genes was between 1 and 5 %. The mean age of DCM onset was the beginning of the fifth decade for all genes. Heart transplantation (HTx) rate was highest in LMNA mutation carriers (27 %), while RBM20 mutation carriers were transplanted at a markedly younger age (mean 28.5 years). While 73 % of DCMpatients with LMNA mutations showed cardiac conduction diseases, low voltage was the reported ECG hallmark in PLN mutation carriers. The frequency of ventricular arrhythmia in DCMpatients with LMNA (50 %) and PLN (43 %) mutations was significantly higher. The penetrance of DCM phenotype in subjects with TTN truncating variants increased with age and reached 100 % by age of 70. CONCLUSION: A pooled analysis of available genotype-phenotype data shows a higher prevalence of sudden cardiac death (SCD), cardiac transplantation, or ventricular arrhythmias in LMNA and PLN mutation carriers compared to sarcomeric gene mutations. This study will further support the clinical interpretation of genetic findings.
Authors: Matthew R G Taylor; Pamela R Fain; Gianfranco Sinagra; Misi L Robinson; Alastair D Robertson; Elisa Carniel; Andrea Di Lenarda; Teresa J Bohlmeyer; Debra A Ferguson; Gary L Brodsky; Mark M Boucek; Jean Lascor; Andrew C Moss; Wai Lun P Li; Gary L Stetler; Francesco Muntoni; Michael R Bristow; Luisa Mestroni Journal: J Am Coll Cardiol Date: 2003-03-05 Impact factor: 24.094
Authors: Guan-Sheng Liu; Ana Morales; Elizabeth Vafiadaki; Chi Keung Lam; Wen-Feng Cai; Kobra Haghighi; George Adly; Ray E Hershberger; Evangelia G Kranias Journal: Cardiovasc Res Date: 2015-04-07 Impact factor: 10.787
Authors: L Mestroni; B Maisch; W J McKenna; K Schwartz; P Charron; C Rocco; F Tesson; A Richter; A Wilke; M Komajda Journal: Eur Heart J Date: 1999-01 Impact factor: 29.983
Authors: Sharie B Parks; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Susan Ludwigsen; Amanda Peterson; Duanxiang Li; Petra Jakobs; Michael Litt; Charles B Porter; Peter S Rahko; Ray E Hershberger Journal: Am Heart J Date: 2008-03-12 Impact factor: 4.749
Authors: Maximilian G Posch; Andreas Perrot; Christian Geier; Leif-Hendrik Boldt; Gunther Schmidt; Hans B Lehmkuhl; Roland Hetzer; Rainer Dietz; Matthias Gutberlet; Wilhelm Haverkamp; Cemil Ozcelik Journal: Heart Rhythm Date: 2009-01-18 Impact factor: 6.343
Authors: Manuel Hermida-Prieto; Lorenzo Monserrat; Alfonso Castro-Beiras; Rafael Laredo; Rafaela Soler; Jesus Peteiro; Esther Rodríguez; Beatriz Bouzas; Nemesio Alvarez; Javier Muñiz; Marisa Crespo-Leiro Journal: Am J Cardiol Date: 2004-07-01 Impact factor: 2.778
Authors: Neal K Lakdawala; Jens J Thune; Steven D Colan; Allison L Cirino; Faranak Farrohi; Jose Rivero; Barbara McDonough; Elizabeth Sparks; E J Orav; J G Seidman; Christine E Seidman; Carolyn Y Ho Journal: Circ Cardiovasc Genet Date: 2012-09-04
Authors: Farbod Sedaghat-Hamedani; Elham Kayvanpour; Oguz Firat Tugrul; Alan Lai; Ali Amr; Jan Haas; Tanja Proctor; Philipp Ehlermann; Katrin Jensen; Hugo A Katus; Benjamin Meder Journal: Clin Res Cardiol Date: 2017-08-24 Impact factor: 5.460
Authors: Biqi Wang; Kathryn L Lunetta; Josée Dupuis; Steven A Lubitz; Ludovic Trinquart; Lixia Yao; Patrick T Ellinor; Emelia J Benjamin; Honghuang Lin Journal: Circ Res Date: 2019-12-05 Impact factor: 17.367
Authors: Tomas Robyns; Rik Willems; Johan Van Cleemput; Shalini Jhangiani; Donna Muzny; Richard Gibbs; James R Lupski; Jeroen Breckpot; Koenraad Devriendt; Anniek Corveleyn Journal: Acta Cardiol Date: 2019-10-04 Impact factor: 1.718